HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Valproic acid (Primary) ; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 20 Jul 2011 Biomarkers information updated
- 24 Jan 2008 Status changed from initiated to recruiting.
- 13 Sep 2007 New trial record.